Businessfrom24/7 Wall St.4 days agoTwo Paths to Growth: Johnson & Johnson vs AbbVieJohnson & Johnson and AbbVie beat Q1 2026 revenue expectations and raised full-year guidance using different growth engines despite biosimilar pressures.